Evidence map›Paper›PMID 22920090›Full record

ArticleMedicinal chemistry (Shariqah (United Arab Emirates))2013

Quantitative structure-activity relationships of imidazole-containing farnesyltransferase inhibitors using different chemometric methods.

Ali Shayanfar, Saeed Ghasemi, Somaieh Soltani, Karim Asadpour-Zeynali, Robert J Doerksen, Abolghasem Jouyban

Abstract read
In one paragraph

Article in Medicinal chemistry (Shariqah (United Arab Emirates)), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ali ShayanfarDepartment of Medicinal Chemistry, Tabriz University of Medical Sciences, Tabriz, Iran. alishayanf@yahoo.co.uk
Saeed Ghasemi
Somaieh Soltani
Karim Asadpour-Zeynali
Robert J Doerksen
Abolghasem Jouyban

Funding

RENOVATION OF FOURTH FLOOR OF FASER HALLC06RR014503 · NCRR · UNIVERSITY OF MISSISSIPPI · PI WELLS, BARBARA G · 1999 to 1999
–
NCRR NIH HHS C06 RR014503NCRR NIH HHS C06 RR-14503-01
6 · The paper itself

Abstract

Farnesyltranseferase inhibitors (FTIs) are one of the most promising classes of anticancer agents, but though some compounds in this category are in clinical trials there are no marketed drugs in this class yet. Quantitative structure activity relationship (QSAR) models can be used for predicting the activity of FTI candidates in early stages of drug discovery. In this study 192 imidazole-containing FTIs were obtained from the literature, structures of the molecules were optimized using Hyperchem software, and molecular descriptors were calculated using Dragon software. The most suitable descriptors were selected using genetic algorithms-partial least squares (GA-PLS) and stepwise regression, and indicated that the volume, shape and polarity of the FTIs are important for their activities. 2D-QSAR models were prepared using both linear methods, i.e., multiple linear regression (MLR), and non-linear methods, i.e., artificial neural networks (ANN) and support vector machines (SVM). The proposed QSAR models were validated using internal and external validation methods. The results show that the proposed 2D-QSAR models are valid and that they can be applied to predict the activities of imidazole-containing FTIs. The prediction capability of the 2D-QSAR (linear and non-linear) models is comparable to and somewhat better than that of previous 3D-QSAR models and the non-linear models are more accurate than the linear models.

Indexed as

Models, BiologicalAntineoplastic AgentsFarnesyltranstransferaseHumansImidazolesInhibitory Concentration 50Molecular StructureQuantitative Structure-Activity RelationshipQuinolonesSoftwareAntineoplastic AgentsFarnesyltranstransferaseimidazoleImidazolesQuinolonestipifarnib

Identifiers

PMID22920090
PMCPMC11437726

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.